http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105399848-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-00 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08B37-0003 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08B37-0063 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-737 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-737 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-125 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
filingDate | 2015-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2017-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2017-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-105399848-B |
titleOfInvention | A kind of fucoidan, preparation method and use |
abstract | The invention provides the fucoidan shown in a kind of following formula with and its production and use.Proved through experiment in vitro, the fucoidan can significantly inhibit the generation of new vessels, so as to realize antitumor activity.Further study showed that the fucoidan anti-angiogenesis is by being combined with key cytokines BMP4 in angiogenesis, suppressing its signal path and realize.The fucoidan is expected to turn into the potential polysaccharide medicine for preventing or treating tumour. |
priorityDate | 2015-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 88.